Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 660 across all filing types
Latest filing 2026-05-20 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于股份回购实施结果暨股份变动的公告
Transaction in Own Shares Classification · 92% confidence The document is an official announcement by Shenzhen Huitai Medical Devices Co., Ltd. detailing the implementation results of its share repurchase program (including number of shares repurchased, amounts, prices, and subsequent shareholding changes) and the intended use of repurchased shares. It is not a regulatory filing about a meeting, not a management report with financial statements, and not an investor presentation. It clearly describes a transaction in the company's own shares (share buyback). Therefore, it falls under Transaction in Own Shares (POS).
2026-05-20 Chinese
关于董事长增持股份计划实施完毕暨增持结果的公告
Director's Dealing Classification · 93% confidence The document is an announcement disclosing the completion and results of the company chairman’s personal share purchase plan, detailing the number of shares acquired, timing, and insider identity. This fits the ‘Director’s Dealing’ category, as it reports a director’s or executive’s personal transaction in company shares. It is not a company share buyback (POS), nor a general major shareholding change by an institutional or strategic investor (MRQ).
2026-05-14 Chinese
关于以集中竞价方式首次回购股份的公告
Transaction in Own Shares Classification · 96% confidence The document is a formal announcement by Shenzhen Huitai Medical Instruments Co., Ltd. describing the company’s first share repurchase via centralized bidding, including repurchase plan details, implementation period, amounts, progress, and legal compliance. This falls squarely under the category of a transaction in own shares (share buybacks).
2026-05-14 Chinese
关于回购股份事项的前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 92% confidence The document is a formal announcement in Chinese specifying details of the top ten shareholders and top ten unrestricted shareholders as required under the company’s share repurchase rules (“回购股份事项”). It is clearly about the company buying back its own shares and discloses shareholding figures in connection with the repurchase. According to our taxonomy, this falls under Transaction in Own Shares (Code: POS).
2026-05-14 Chinese
关于以集中竞价交易方式回购股份的回购报告书
Transaction in Own Shares Classification · 95% confidence The document is a detailed repurchase report (“回购报告书”) outlining a share buyback plan: amount, sources, pricing, procedures, board approvals, and related disclosures. This clearly corresponds to a report of the company buying back its own shares. Under the taxonomy, this fits Transaction in Own Shares (Code: POS).
2026-05-12 Chinese
关于调整2021年限制性股票激励计划授予价格的公告
Share Issue/Capital Change Classification · 75% confidence The document is a public announcement by Shenzhen Huitai Medical Equipment Co., Ltd. detailing the board’s approval and legal opinions on adjusting the grant price of its 2021 restricted stock incentive plan. It is not a general financial report, earnings release, proxy statement, or certification; rather, it concerns a corporate action on share issuance terms (the incentive stock grant price). This falls under capital changes/issuance of new shares. Therefore, the correct category is Share Issue/Capital Change (SHA).
2026-05-11 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.